BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 11042379)

  • 1. The iron chelator pyridoxal isonicotinoyl hydrazone (PIH) and its analogues prevent damage to 2-deoxyribose mediated by ferric iron plus ascorbate.
    Hermes-Lima M; Ponka P; Schulman HM
    Biochim Biophys Acta; 2000 Oct; 1523(2-3):154-60. PubMed ID: 11042379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pyridoxal isonicotinoyl hydrazone inhibits iron-induced ascorbate oxidation and ascorbyl radical formation.
    Maurício AQ; Lopes GK; Gomes CS; Oliveira RG; Alonso A; Hermes-Lima M
    Biochim Biophys Acta; 2003 Mar; 1620(1-3):15-24. PubMed ID: 12595068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EPR spin trapping and 2-deoxyribose degradation studies of the effect of pyridoxal isonicotinoyl hydrazone (PIH) on *OH formation by the Fenton reaction.
    Hermes-Lima M; Santos NC; Yan J; Andrews M; Schulman HM; Ponka P
    Biochim Biophys Acta; 1999 Feb; 1426(3):475-82. PubMed ID: 10076064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pyridoxal isonicotinoyl hydrazone (PIH) prevents copper-mediated in vitro free radical formation.
    Hermes-Lima M; Gonçalves MS; Andrade RG
    Mol Cell Biochem; 2001 Dec; 228(1-2):73-82. PubMed ID: 11855743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The iron chelator pyridoxal isonicotinoyl hydrazone (PIH) protects plasmid pUC-18 DNA against *OH-mediated strand breaks.
    Hermes-Lima M; Nagy E; Ponka P; Schulman HM
    Free Radic Biol Med; 1998 Nov; 25(8):875-80. PubMed ID: 9840731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual mechanism of mangiferin protection against iron-induced damage to 2-deoxyribose and ascorbate oxidation.
    Pardo-Andreu GL; Delgado R; Núñez-Sellés AJ; Vercesi AE
    Pharmacol Res; 2006 Mar; 53(3):253-60. PubMed ID: 16412661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The iron chelator pyridoxal isonicotinoyl hydrazone inhibits mitochondrial lipid peroxidation induced by Fe(II)-citrate.
    Santos NC; Castilho RF; Meinicke AR; Hermes-Lima M
    Eur J Pharmacol; 2001 Sep; 428(1):37-44. PubMed ID: 11779035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pyridoxal isonicotinoyl hydrazone and its analogs: potential orally effective iron-chelating agents for the treatment of iron overload disease.
    Richardson DR; Ponka P
    J Lab Clin Med; 1998 Apr; 131(4):306-15. PubMed ID: 9579383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The potential of iron chelators of the pyridoxal isonicotinoyl hydrazone class as effective antiproliferative agents.
    Richardson DR; Tran EH; Ponka P
    Blood; 1995 Dec; 86(11):4295-306. PubMed ID: 7492790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro antioxidant properties of the iron chelator pyridoxal isonicotinoyl hydrazone and some of its analogs.
    Schulman HM; Hermes-Lima M; Wang EM; Ponka P
    Redox Rep; 1995 Nov; 1(5):373-8. PubMed ID: 27405837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The interaction of pyridoxal isonicotinoyl hydrazone (PIH) and salicylaldehyde isonicotinoyl hydrazone (SIH) with iron.
    Chen YL; Kong X; Xie Y; Hider RC
    J Inorg Biochem; 2018 Mar; 180():194-203. PubMed ID: 29329026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidative stress mediates toxicity of pyridoxal isonicotinoyl hydrazone analogs.
    Buss JL; Neuzil J; Ponka P
    Arch Biochem Biophys; 2004 Jan; 421(1):1-9. PubMed ID: 14678779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The potential of iron chelators of the pyridoxal isonicotinoyl hydrazone class as effective antiproliferative agents II: the mechanism of action of ligands derived from salicylaldehyde benzoyl hydrazone and 2-hydroxy-1-naphthylaldehyde benzoyl hydrazone.
    Richardson DR; Milnes K
    Blood; 1997 Apr; 89(8):3025-38. PubMed ID: 9108424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mangifera indica L. extract (Vimang) inhibits 2-deoxyribose damage induced by Fe (III) plus ascorbate.
    Pardo-Andreu GL; Delgado R; Núñez-Sellés AJ; Vercesi AE
    Phytother Res; 2006 Feb; 20(2):120-4. PubMed ID: 16444664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Examination of the antiproliferative activity of iron chelators: multiple cellular targets and the different mechanism of action of triapine compared with desferrioxamine and the potent pyridoxal isonicotinoyl hydrazone analogue 311.
    Chaston TB; Lovejoy DB; Watts RN; Richardson DR
    Clin Cancer Res; 2003 Jan; 9(1):402-14. PubMed ID: 12538494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The hydrolysis product of ICRF-187 promotes iron-catalysed hydroxyl radical production via the Fenton reaction.
    Thomas C; Vile GF; Winterbourn CC
    Biochem Pharmacol; 1993 May; 45(10):1967-72. PubMed ID: 8390256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Iron chelation by pyridoxal isonicotinoyl hydrazone and analogues in hepatocytes in culture.
    Baker E; Vitolo ML; Webb J
    Biochem Pharmacol; 1985 Sep; 34(17):3011-7. PubMed ID: 4038321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polyphenol tannic acid inhibits hydroxyl radical formation from Fenton reaction by complexing ferrous ions.
    Lopes GK; Schulman HM; Hermes-Lima M
    Biochim Biophys Acta; 1999 Oct; 1472(1-2):142-52. PubMed ID: 10572935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of combined chelation treatment with pyridoxal isonicotinoyl hydrazone analogs and deferoxamine in hypertransfused rats and in iron-loaded rat heart cells.
    Link G; Ponka P; Konijn AM; Breuer W; Cabantchik ZI; Hershko C
    Blood; 2003 May; 101(10):4172-9. PubMed ID: 12511418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A study of the mechanism of action of pyridoxal isonicotinoyl hydrazone at the cellular level using reticulocytes loaded with non-heme 59Fe.
    Huang AR; Ponka P
    Biochim Biophys Acta; 1983 Jun; 757(3):306-15. PubMed ID: 6849979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.